img

Global Tofacitinib Citrate Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tofacitinib Citrate Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tofacitinib Citrate Tablets is an immunosuppressant, which affects the cellular hematopoietic process and cellular immune function by conducting the signals generated by the cytokine or growth factor-receptor interaction on the cell membrane.
Tofacitinib Citrate Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tofacitinib Citrate Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tofacitinib Citrate Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tofacitinib Citrate Tablets key manufacturers include Pfizer, Zhejiang Hisun Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Hunan Jiudian Pharmaceutical Co., Ltd., CSPC OUYI Pharmaceutical Co., Ltd., Chengdu Brilliant Pharmaceutical Co., Ltd., Simcere Pharmaceutical Group Limited, Sinomune Pharmaceutical Co., Ltd. and QILU Pharmaceutical Co., Ltd., etc. Pfizer, Zhejiang Hisun Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
Tofacitinib Citrate Tablets can be divided into 14 tablets/bottle, 28 tablets/bottle and Other Specifications,, etc. 14 tablets/bottle is the mainstream product in the market, accounting for % sales share globally in 2022.
Tofacitinib Citrate Tablets is widely used in various fields, such as Hospital, Retail Pharmacy, Clinic and Others, etc. Hospital provides greatest supports to the Tofacitinib Citrate Tablets industry development. In 2022, global % sales of Tofacitinib Citrate Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tofacitinib Citrate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Zhejiang Hisun Pharmaceutical Co., Ltd.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Hunan Jiudian Pharmaceutical Co., Ltd.
CSPC OUYI Pharmaceutical Co., Ltd.
Chengdu Brilliant Pharmaceutical Co., Ltd.
Simcere Pharmaceutical Group Limited
Sinomune Pharmaceutical Co., Ltd.
QILU Pharmaceutical Co., Ltd.
Hangzhou zuyaxi MedicineCo.,Ltd.
SPH Zhongxi Pharmaceutical Co., Ltd.
Hunan Kelun Pharmaceutical Co., Ltd.
Segment by Type
14 tablets/bottle
28 tablets/bottle
Other Specifications

Segment by Application


Hospital
Retail Pharmacy
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tofacitinib Citrate Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tofacitinib Citrate Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tofacitinib Citrate Tablets industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tofacitinib Citrate Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tofacitinib Citrate Tablets introduction, etc. Tofacitinib Citrate Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Tofacitinib Citrate Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Tofacitinib Citrate Tablets Market Overview
1.1 Tofacitinib Citrate Tablets Product Overview
1.2 Tofacitinib Citrate Tablets Market Segment by Type
1.2.1 14 tablets/bottle
1.2.2 28 tablets/bottle
1.2.3 Other Specifications
1.3 Global Tofacitinib Citrate Tablets Market Size by Type
1.3.1 Global Tofacitinib Citrate Tablets Market Size Overview by Type (2018-2034)
1.3.2 Global Tofacitinib Citrate Tablets Historic Market Size Review by Type (2018-2024)
1.3.3 Global Tofacitinib Citrate Tablets Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tofacitinib Citrate Tablets Sales Breakdown by Type (2018-2024)
1.4.2 Europe Tofacitinib Citrate Tablets Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Tofacitinib Citrate Tablets Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Tofacitinib Citrate Tablets Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Tofacitinib Citrate Tablets Sales Breakdown by Type (2018-2024)
2 Global Tofacitinib Citrate Tablets Market Competition by Company
2.1 Global Top Players by Tofacitinib Citrate Tablets Sales (2018-2024)
2.2 Global Top Players by Tofacitinib Citrate Tablets Revenue (2018-2024)
2.3 Global Top Players by Tofacitinib Citrate Tablets Price (2018-2024)
2.4 Global Top Manufacturers Tofacitinib Citrate Tablets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tofacitinib Citrate Tablets Market Competitive Situation and Trends
2.5.1 Tofacitinib Citrate Tablets Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tofacitinib Citrate Tablets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tofacitinib Citrate Tablets as of 2022)
2.7 Date of Key Manufacturers Enter into Tofacitinib Citrate Tablets Market
2.8 Key Manufacturers Tofacitinib Citrate Tablets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tofacitinib Citrate Tablets Status and Outlook by Region
3.1 Global Tofacitinib Citrate Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Tofacitinib Citrate Tablets Historic Market Size by Region
3.2.1 Global Tofacitinib Citrate Tablets Sales in Volume by Region (2018-2024)
3.2.2 Global Tofacitinib Citrate Tablets Sales in Value by Region (2018-2024)
3.2.3 Global Tofacitinib Citrate Tablets Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Tofacitinib Citrate Tablets Forecasted Market Size by Region
3.3.1 Global Tofacitinib Citrate Tablets Sales in Volume by Region (2024-2034)
3.3.2 Global Tofacitinib Citrate Tablets Sales in Value by Region (2024-2034)
3.3.3 Global Tofacitinib Citrate Tablets Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Tofacitinib Citrate Tablets by Application
4.1 Tofacitinib Citrate Tablets Market Segment by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.1.3 Clinic
4.1.4 Others
4.2 Global Tofacitinib Citrate Tablets Market Size by Application
4.2.1 Global Tofacitinib Citrate Tablets Market Size Overview by Application (2018-2034)
4.2.2 Global Tofacitinib Citrate Tablets Historic Market Size Review by Application (2018-2024)
4.2.3 Global Tofacitinib Citrate Tablets Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tofacitinib Citrate Tablets Sales Breakdown by Application (2018-2024)
4.3.2 Europe Tofacitinib Citrate Tablets Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Tofacitinib Citrate Tablets Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Tofacitinib Citrate Tablets Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Tofacitinib Citrate Tablets Sales Breakdown by Application (2018-2024)
5 North America Tofacitinib Citrate Tablets by Country
5.1 North America Tofacitinib Citrate Tablets Historic Market Size by Country
5.1.1 North America Tofacitinib Citrate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Tofacitinib Citrate Tablets Sales in Volume by Country (2018-2024)
5.1.3 North America Tofacitinib Citrate Tablets Sales in Value by Country (2018-2024)
5.2 North America Tofacitinib Citrate Tablets Forecasted Market Size by Country
5.2.1 North America Tofacitinib Citrate Tablets Sales in Volume by Country (2024-2034)
5.2.2 North America Tofacitinib Citrate Tablets Sales in Value by Country (2024-2034)
6 Europe Tofacitinib Citrate Tablets by Country
6.1 Europe Tofacitinib Citrate Tablets Historic Market Size by Country
6.1.1 Europe Tofacitinib Citrate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Tofacitinib Citrate Tablets Sales in Volume by Country (2018-2024)
6.1.3 Europe Tofacitinib Citrate Tablets Sales in Value by Country (2018-2024)
6.2 Europe Tofacitinib Citrate Tablets Forecasted Market Size by Country
6.2.1 Europe Tofacitinib Citrate Tablets Sales in Volume by Country (2024-2034)
6.2.2 Europe Tofacitinib Citrate Tablets Sales in Value by Country (2024-2034)
7 Asia-Pacific Tofacitinib Citrate Tablets by Region
7.1 Asia-Pacific Tofacitinib Citrate Tablets Historic Market Size by Region
7.1.1 Asia-Pacific Tofacitinib Citrate Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Tofacitinib Citrate Tablets Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Tofacitinib Citrate Tablets Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Tofacitinib Citrate Tablets Forecasted Market Size by Region
7.2.1 Asia-Pacific Tofacitinib Citrate Tablets Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Tofacitinib Citrate Tablets Sales in Value by Region (2024-2034)
8 Latin America Tofacitinib Citrate Tablets by Country
8.1 Latin America Tofacitinib Citrate Tablets Historic Market Size by Country
8.1.1 Latin America Tofacitinib Citrate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Tofacitinib Citrate Tablets Sales in Volume by Country (2018-2024)
8.1.3 Latin America Tofacitinib Citrate Tablets Sales in Value by Country (2018-2024)
8.2 Latin America Tofacitinib Citrate Tablets Forecasted Market Size by Country
8.2.1 Latin America Tofacitinib Citrate Tablets Sales in Volume by Country (2024-2034)
8.2.2 Latin America Tofacitinib Citrate Tablets Sales in Value by Country (2024-2034)
9 Middle East and Africa Tofacitinib Citrate Tablets by Country
9.1 Middle East and Africa Tofacitinib Citrate Tablets Historic Market Size by Country
9.1.1 Middle East and Africa Tofacitinib Citrate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Tofacitinib Citrate Tablets Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Tofacitinib Citrate Tablets Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Tofacitinib Citrate Tablets Forecasted Market Size by Country
9.2.1 Middle East and Africa Tofacitinib Citrate Tablets Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Tofacitinib Citrate Tablets Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Tofacitinib Citrate Tablets Products Offered
10.1.5 Pfizer Recent Development
10.2 Zhejiang Hisun Pharmaceutical Co., Ltd.
10.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
10.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Introduction and Business Overview
10.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development
10.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
10.3.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
10.3.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Introduction and Business Overview
10.3.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.3.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Development
10.4 Hunan Jiudian Pharmaceutical Co., Ltd.
10.4.1 Hunan Jiudian Pharmaceutical Co., Ltd. Company Information
10.4.2 Hunan Jiudian Pharmaceutical Co., Ltd. Introduction and Business Overview
10.4.3 Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.4.5 Hunan Jiudian Pharmaceutical Co., Ltd. Recent Development
10.5 CSPC OUYI Pharmaceutical Co., Ltd.
10.5.1 CSPC OUYI Pharmaceutical Co., Ltd. Company Information
10.5.2 CSPC OUYI Pharmaceutical Co., Ltd. Introduction and Business Overview
10.5.3 CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.5.4 CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.5.5 CSPC OUYI Pharmaceutical Co., Ltd. Recent Development
10.6 Chengdu Brilliant Pharmaceutical Co., Ltd.
10.6.1 Chengdu Brilliant Pharmaceutical Co., Ltd. Company Information
10.6.2 Chengdu Brilliant Pharmaceutical Co., Ltd. Introduction and Business Overview
10.6.3 Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.6.5 Chengdu Brilliant Pharmaceutical Co., Ltd. Recent Development
10.7 Simcere Pharmaceutical Group Limited
10.7.1 Simcere Pharmaceutical Group Limited Company Information
10.7.2 Simcere Pharmaceutical Group Limited Introduction and Business Overview
10.7.3 Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Products Offered
10.7.5 Simcere Pharmaceutical Group Limited Recent Development
10.8 Sinomune Pharmaceutical Co., Ltd.
10.8.1 Sinomune Pharmaceutical Co., Ltd. Company Information
10.8.2 Sinomune Pharmaceutical Co., Ltd. Introduction and Business Overview
10.8.3 Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.8.5 Sinomune Pharmaceutical Co., Ltd. Recent Development
10.9 QILU Pharmaceutical Co., Ltd.
10.9.1 QILU Pharmaceutical Co., Ltd. Company Information
10.9.2 QILU Pharmaceutical Co., Ltd. Introduction and Business Overview
10.9.3 QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.9.4 QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.9.5 QILU Pharmaceutical Co., Ltd. Recent Development
10.10 Hangzhou zuyaxi MedicineCo.,Ltd.
10.10.1 Hangzhou zuyaxi MedicineCo.,Ltd. Company Information
10.10.2 Hangzhou zuyaxi MedicineCo.,Ltd. Introduction and Business Overview
10.10.3 Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Products Offered
10.10.5 Hangzhou zuyaxi MedicineCo.,Ltd. Recent Development
10.11 SPH Zhongxi Pharmaceutical Co., Ltd.
10.11.1 SPH Zhongxi Pharmaceutical Co., Ltd. Company Information
10.11.2 SPH Zhongxi Pharmaceutical Co., Ltd. Introduction and Business Overview
10.11.3 SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.11.4 SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.11.5 SPH Zhongxi Pharmaceutical Co., Ltd. Recent Development
10.12 Hunan Kelun Pharmaceutical Co., Ltd.
10.12.1 Hunan Kelun Pharmaceutical Co., Ltd. Company Information
10.12.2 Hunan Kelun Pharmaceutical Co., Ltd. Introduction and Business Overview
10.12.3 Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Products Offered
10.12.5 Hunan Kelun Pharmaceutical Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tofacitinib Citrate Tablets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tofacitinib Citrate Tablets Industrial Chain Analysis
11.4 Tofacitinib Citrate Tablets Market Dynamics
11.4.1 Tofacitinib Citrate Tablets Industry Trends
11.4.2 Tofacitinib Citrate Tablets Market Drivers
11.4.3 Tofacitinib Citrate Tablets Market Challenges
11.4.4 Tofacitinib Citrate Tablets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tofacitinib Citrate Tablets Distributors
12.3 Tofacitinib Citrate Tablets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 14 tablets/bottle
Table 2. Major Company of 28 tablets/bottle
Table 3. Major Company of Other Specifications
Table 4. Global Tofacitinib Citrate Tablets Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (K Units)
Table 6. Global Tofacitinib Citrate Tablets Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (US& Million)
Table 8. Global Tofacitinib Citrate Tablets Market Share in Value by Type (2018-2024)
Table 9. Global Tofacitinib Citrate Tablets Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Tofacitinib Citrate Tablets Sales by Type (2024-2034) & (K Units)
Table 11. Global Tofacitinib Citrate Tablets Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Tofacitinib Citrate Tablets Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Tofacitinib Citrate Tablets Sales Market Share in Value by Type (2024-2034)
Table 14. Global Tofacitinib Citrate Tablets Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (K Units)
Table 16. North America Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Tofacitinib Citrate Tablets Sales (K Units) by Type (2018-2024)
Table 18. Europe Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Tofacitinib Citrate Tablets Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Tofacitinib Citrate Tablets Sales (K Units) by Type (2018-2024)
Table 22. Latin America Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Tofacitinib Citrate Tablets Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Tofacitinib Citrate Tablets Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Tofacitinib Citrate Tablets Sales by Company (2018-2024) & (K Units)
Table 26. Global Tofacitinib Citrate Tablets Sales Share by Company (2018-2024)
Table 27. Global Tofacitinib Citrate Tablets Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Tofacitinib Citrate Tablets Revenue Share by Company (2018-2024)
Table 29. Global Market Tofacitinib Citrate Tablets Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Tofacitinib Citrate Tablets Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Tofacitinib Citrate Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tofacitinib Citrate Tablets as of 2022)
Table 33. Date of Key Manufacturers Enter into Tofacitinib Citrate Tablets Market
Table 34. Key Manufacturers Tofacitinib Citrate Tablets Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Tofacitinib Citrate Tablets Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Tofacitinib Citrate Tablets Sales by Region (2018-2024) & (K Units)
Table 38. Global Tofacitinib Citrate Tablets Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Tofacitinib Citrate Tablets Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Tofacitinib Citrate Tablets Sales Market Share in Value by Region (2018-2024)
Table 41. Global Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Tofacitinib Citrate Tablets Sales by Region (2024-2034) & (K Units)
Table 43. Global Tofacitinib Citrate Tablets Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Tofacitinib Citrate Tablets Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Tofacitinib Citrate Tablets Sales Market Share in Value by Region (2024-2034)
Table 46. Global Tofacitinib Citrate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Tofacitinib Citrate Tablets Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Tofacitinib Citrate Tablets Sales by Application (2018-2024) & (K Units)
Table 49. Global Tofacitinib Citrate Tablets Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Tofacitinib Citrate Tablets Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Tofacitinib Citrate Tablets Sales Market Share in Value by Application (2018-2024)
Table 52. Global Tofacitinib Citrate Tablets Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Tofacitinib Citrate Tablets Sales by Application (2024-2034) & (K Units)
Table 54. Global Tofacitinib Citrate Tablets Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Tofacitinib Citrate Tablets Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Tofacitinib Citrate Tablets Sales Market Share in Value by Application (2024-2034)
Table 57. Global Tofacitinib Citrate Tablets Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Tofacitinib Citrate Tablets Sales by Application (2018-2024) (K Units)
Table 59. North America Tofacitinib Citrate Tablets Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Tofacitinib Citrate Tablets Sales by Application (2018-2024) (K Units)
Table 61. Europe Tofacitinib Citrate Tablets Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Tofacitinib Citrate Tablets Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Tofacitinib Citrate Tablets Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Tofacitinib Citrate Tablets Sales by Application (2018-2024) (K Units)
Table 65. Latin America Tofacitinib Citrate Tablets Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Tofacitinib Citrate Tablets Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Tofacitinib Citrate Tablets Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (K Units)
Table 69. North America Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2018-2024)
Table 72. North America Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (K Units)
Table 73. North America Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (K Units)
Table 77. Europe Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (K Units)
Table 81. Europe Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Tofacitinib Citrate Tablets Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Tofacitinib Citrate Tablets Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Tofacitinib Citrate Tablets Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Tofacitinib Citrate Tablets Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Tofacitinib Citrate Tablets Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Tofacitinib Citrate Tablets Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share in Value by Country (2024-2034)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Tofacitinib Citrate Tablets Product
Table 112. Pfizer Recent Development
Table 113. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
Table 114. Zhejiang Hisun Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 115. Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Zhejiang Hisun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 117. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development
Table 118. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
Table 119. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 120. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 122. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Development
Table 123. Hunan Jiudian Pharmaceutical Co., Ltd. Company Information
Table 124. Hunan Jiudian Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 125. Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Hunan Jiudian Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 127. Hunan Jiudian Pharmaceutical Co., Ltd. Recent Development
Table 128. CSPC OUYI Pharmaceutical Co., Ltd. Company Information
Table 129. CSPC OUYI Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 130. CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. CSPC OUYI Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 132. CSPC OUYI Pharmaceutical Co., Ltd. Recent Development
Table 133. Chengdu Brilliant Pharmaceutical Co., Ltd. Company Information
Table 134. Chengdu Brilliant Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 135. Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Chengdu Brilliant Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 137. Chengdu Brilliant Pharmaceutical Co., Ltd. Recent Development
Table 138. Simcere Pharmaceutical Group Limited Company Information
Table 139. Simcere Pharmaceutical Group Limited Introduction and Business Overview
Table 140. Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Simcere Pharmaceutical Group Limited Tofacitinib Citrate Tablets Product
Table 142. Simcere Pharmaceutical Group Limited Recent Development
Table 143. Sinomune Pharmaceutical Co., Ltd. Company Information
Table 144. Sinomune Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 145. Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Sinomune Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 147. Sinomune Pharmaceutical Co., Ltd. Recent Development
Table 148. QILU Pharmaceutical Co., Ltd. Company Information
Table 149. QILU Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 150. QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. QILU Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 152. QILU Pharmaceutical Co., Ltd. Recent Development
Table 153. Hangzhou zuyaxi MedicineCo.,Ltd. Company Information
Table 154. Hangzhou zuyaxi MedicineCo.,Ltd. Introduction and Business Overview
Table 155. Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Hangzhou zuyaxi MedicineCo.,Ltd. Tofacitinib Citrate Tablets Product
Table 157. Hangzhou zuyaxi MedicineCo.,Ltd. Recent Development
Table 158. SPH Zhongxi Pharmaceutical Co., Ltd. Company Information
Table 159. SPH Zhongxi Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 160. SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. SPH Zhongxi Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 162. SPH Zhongxi Pharmaceutical Co., Ltd. Recent Development
Table 163. Hunan Kelun Pharmaceutical Co., Ltd. Company Information
Table 164. Hunan Kelun Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 165. Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Hunan Kelun Pharmaceutical Co., Ltd. Tofacitinib Citrate Tablets Product
Table 167. Hunan Kelun Pharmaceutical Co., Ltd. Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Tofacitinib Citrate Tablets Market Trends
Table 171. Tofacitinib Citrate Tablets Market Drivers
Table 172. Tofacitinib Citrate Tablets Market Challenges
Table 173. Tofacitinib Citrate Tablets Market Restraints
Table 174. Tofacitinib Citrate Tablets Distributors List
Table 175. Tofacitinib Citrate Tablets Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Tofacitinib Citrate Tablets Product Picture
Figure 2. Global Tofacitinib Citrate Tablets Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Tofacitinib Citrate Tablets Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Tofacitinib Citrate Tablets Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of 14 tablets/bottle
Figure 6. Global 14 tablets/bottle Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of 28 tablets/bottle
Figure 8. Global 28 tablets/bottle Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Other Specifications
Figure 10. Global Other Specifications Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Tofacitinib Citrate Tablets Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Tofacitinib Citrate Tablets Sales Market Share by Type in 2022 & 2034
Figure 13. North America Tofacitinib Citrate Tablets Sales Market Share in Volume by Type in 2022
Figure 14. North America Tofacitinib Citrate Tablets Sales Market Share in Value by Type in 2022
Figure 15. Europe Tofacitinib Citrate Tablets Sales Market Share in Volume by Type in 2022
Figure 16. Europe Tofacitinib Citrate Tablets Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Value by Type in 2022
Figure 19. Latin America Tofacitinib Citrate Tablets Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Tofacitinib Citrate Tablets Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Tofacitinib Citrate Tablets Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Tofacitinib Citrate Tablets Revenue in 2022
Figure 25. Tofacitinib Citrate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Retail Pharmacy
Figure 29. Global Retail Pharmacy Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Tofacitinib Citrate Tablets Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Tofacitinib Citrate Tablets Sales Market Share by Application in 2022 & 2034
Figure 36. North America Tofacitinib Citrate Tablets Sales Market Share in Volume by Application in 2022
Figure 37. North America Tofacitinib Citrate Tablets Sales Market Share in Value by Application in 2022
Figure 38. Europe Tofacitinib Citrate Tablets Sales Market Share in Volume by Application in 2022
Figure 39. Europe Tofacitinib Citrate Tablets Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Tofacitinib Citrate Tablets Sales Market Share in Value by Application in 2022
Figure 42. Latin America Tofacitinib Citrate Tablets Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Tofacitinib Citrate Tablets Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Tofacitinib Citrate Tablets Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Tofacitinib Citrate Tablets Manufacturing Cost Structure
Figure 47. Tofacitinib Citrate Tablets Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed